Home › Funds › Velan Capital Investment Management LP › CNTX

Velan Capital Investment Management LP position in CNTX

CONTEXT THERAPEUTICS INC · Health Care

Velan Capital Investment Management LP reported holding 59,700 shares of CNTX (CONTEXT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$33K, representing 0.02% of its reported portfolio and ranking #49 among its reported holdings. Velan Capital Investment Management LP has disclosed CNTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)59.70K sh
Reported value held$33.07K
Portfolio Weight0.02%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's CNTX position evolved

Velan Capital Investment Management LP first disclosed a stake in CNTX in Q2 2024 at 1,290,323 shares (US$2.6M). Across 9 filings, Velan Capital Investment Management LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 59,700 shares valued at US$33K — a reduction of -40,300 shares quarter over quarter.. Notable position changes include a 93% trim in Q4 2024 (shares fell 42% over the following quarter), a 40% trim in Q2 2026 (shares fell 46% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 1.29M $2.59M New
Q3 2024 1.29M $2.53M Hold
Q4 2024 90.00K $94.50K Reduce
Q1 2025 90.00K $55.08K Hold
Q2 2025 100.00K $65.52K Add
Q3 2025 100.00K $96.88K Hold
Q4 2025 100.00K $147.00K Hold
Q1 2026 100.00K $262.00K Hold
Q2 2026 59.70K $33.07K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CNTX and 13F data

CNTX (CONTEXT THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in CNTX — the largest reported positions include Nextech Invest Ltd. (US$4.1M), Avidity Partners Management LP (US$2.8M), Octagon Capital Advisors LP (US$1.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CNTX

All CNTX fund holders →

FAQ

How long has Velan Capital Investment Management LP held CNTX?

Velan Capital Investment Management LP has disclosed CNTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is Velan Capital Investment Management LP's current position in CNTX?

As of Q2 2026, Velan Capital Investment Management LP holds 59.70K shares of CNTX (CONTEXT THERAPEUTICS INC), valued at $33.07K, representing 0.02% of its reported portfolio and ranking #49.

Has Velan Capital Investment Management LP been buying or selling CNTX?

In the latest 13F filing (Q2 2026), Velan Capital Investment Management LP reduced its position in CNTX.

Which other funds hold CNTX?

Other major institutional holders of CNTX include Nextech Invest Ltd., Avidity Partners Management LP, Octagon Capital Advisors LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.